| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827352 | Schizophrenia Research | 2012 | 7 Pages |
Abstract
What constitutes maintenance phase and its treatment in schizophrenia has not yet been established in the literature. While discontinuation and intermittent or targeted strategies are not generally recommended, there is controversy regarding dose reduction or lower dose therapy, especially with regards to atypical antipsychotics. Further evidence is needed in order to derive treatment recommendations on antipsychotics in this critical treatment phase of schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Hiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Masaru Mimura,